Kaushalya Suthar
Kaushalya Suthar
Kaushalya Suthar
PATIENT ID :
PATIENT NAME : KAUSHALYA SUTHAR
ACCESSION NO : 0284TK011800 AGE : 28 Years SEX : Female
HAEMATOLOGY
CBC-5, EDTA WHOLE BLOOD
BLOOD COUNTS
HEMOGLOBIN 14.7 13.0 - 17.0 g/dL
RED BLOOD CELL COUNT 5.38 4.5 - 5.5 mil/µL
WHITE BLOOD CELL COUNT 4.1 4.0 - 10.0 thou/µL
PLATELET COUNT 151 150 - 410 thou/µL
RBC AND PLATELET INDICES
HEMATOCRIT 48.1 40 - 50 %
MEAN CORPUSCULAR VOLUME 85.0 83.0 - 101.0 fL
MEAN CORPUSCULAR HEMOGLOBIN 30.9 27.0 - 32.0 pg
MEAN CORPUSCULAR HEMOGLOBIN 34.2 31.5 - 34.5 g/dL
CONCENTRATION
RED CELL DISTRIBUTION WIDTH 13.7 11.6 - 14.0 %
MEAN PLATELET VOLUME 9.3 6.8 - 10.9 fL
WBC DIFFERENTIAL COUNT - NLR
NEUTROPHILS 59 40 - 80 %
ABSOLUTE NEUTROPHIL COUNT 2.23 2.0 - 7.0 thou/µL
LYMPHOCYTES 34 20 - 40 %
ABSOLUTE LYMPHOCYTE COUNT 1.09 1.0 - 3.0 thou/µL
NEUTROPHIL LYMPHOCYTE RATIO (NLR) 1.6
EOSINOPHILS 04 1-6 %
ABSOLUTE EOSINOPHIL COUNT 0.06 0.02 - 0.50 thou/µL
MONOCYTES 03 2 - 10 %
ABSOLUTE MONOCYTE COUNT 0.09 Low 0.2 - 1.0 thou/µL
Interpretation(s)
WBC DIFFERENTIAL COUNT - NLR-The optimal threshold of 3.3 for NLR showed a prognostic possibility of clinical symptoms to change from mild to severe in COVID positive
patients. When age = 49.5 years old and NLR = 3.3, 46.1% COVID-19 patients with mild disease might become severe. By contrast, when age < 49.5 years old and NLR <
3.3, COVID-19 patients tend to show mild disease.
(Reference to - The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients A.-P. Yang, et al. International Immunopharmacology 84 (2020) 106504
This ratio element is a calculated parameter and out of NABL scope.
**End Of Report**
Page 1 Of 2
........................
Please visit www.srlworld.com for related Test Information for this accession .......................
............ .........................
....... .... ........
....................
PATIENT ID :
PATIENT NAME : KAUSHLYA SUTHAR
ACCESSION NO : 0284TK0118800 AGE : 28 Years SEX : Female
Dr.Suwarna kawade
Consultant Pathologist
Page 2 Of 2
..................
............
.